Aspen Aerogels, Inc. (NYSE:ASPN) CAO Sells $15,080.00 in Stock

Key Points

• Aspen Aerogels' CAO Santhosh P. Daniel sold 2,000 shares of stock for a total of $15,080, reducing his position by 10.06%.
• The company's stock is currently valued at $7.50, with a market cap of $617.70 million and a P/E ratio of -1.97.
• Despite a 33.8% revenue decline year-over-year, Aspen Aerogels reported better-than-expected earnings, with an EPS of ($0.04) compared to a consensus estimate of ($0.12).

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) CAO Santhosh P. Daniel sold 2,000 shares of the company's stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $7.54, for a total value of $15,080.00. Following the sale, the chief accounting officer owned 17,879 shares of the company's stock, valued at $134,807.66. This trade represents a 10.06% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Aspen Aerogels Stock Performance

Shares of NYSE ASPN traded up $0.08 during trading on Wednesday, reaching $7.50. 2,478,212 shares of the stock traded hands, compared to its average volume of 2,058,091. Aspen Aerogels, Inc. has a 52-week low of $4.16 and a 52-week high of $33.15. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. The company has a 50-day moving average of $6.78 and a 200-day moving average of $7.00. The stock has a market capitalization of $617.70 million, a P/E ratio of -1.97 and a beta of 2.73.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%. The firm had revenue of $78.02 million for the quarter, compared to analysts' expectations of $72.53 million. During the same quarter in the prior year, the firm earned $0.21 EPS. The business's revenue for the quarter was down 33.8% compared to the same quarter last year. Analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Institutional Trading of Aspen Aerogels

Institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in shares of Aspen Aerogels by 0.3% in the 1st quarter. Vanguard Group Inc. now owns 4,373,159 shares of the construction company's stock valued at $27,944,000 after acquiring an additional 12,913 shares in the last quarter. Oaktop Capital Management II L.P. raised its holdings in shares of Aspen Aerogels by 5.6% in the 4th quarter. Oaktop Capital Management II L.P. now owns 3,740,525 shares of the construction company's stock valued at $44,437,000 after acquiring an additional 200,000 shares in the last quarter. Needham Investment Management LLC raised its holdings in shares of Aspen Aerogels by 14.5% in the 1st quarter. Needham Investment Management LLC now owns 2,737,200 shares of the construction company's stock valued at $17,491,000 after acquiring an additional 347,500 shares in the last quarter. AWM Investment Company Inc. raised its holdings in shares of Aspen Aerogels by 102.6% in the 1st quarter. AWM Investment Company Inc. now owns 2,449,221 shares of the construction company's stock valued at $15,651,000 after acquiring an additional 1,240,535 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Aspen Aerogels by 25.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,018,631 shares of the construction company's stock valued at $23,983,000 after acquiring an additional 409,862 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analyst Ratings Changes

Several brokerages recently issued reports on ASPN. Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a report on Thursday, May 8th. Barclays cut Aspen Aerogels from an "equal weight" rating to an "underweight" rating and boosted their price objective for the stock from $7.00 to $16.00 in a research report on Monday. Finally, Canaccord Genuity Group cut their price objective on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $19.50.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.